·Ryculture Health and Social Innovation·Est. 2018

Your

Gateway

to Africa's

Life Science Markets.

We build resilient health systems and nurture the people who sustain them — through research, advocacy, and radical community investment across Africa.

Scroll
Humanity ·Integrity ·Professionalism ·Client Value Creation ·Teamwork ·Humanity ·Integrity ·Professionalism ·Client Value Creation ·Teamwork ·Humanity ·Integrity ·Professionalism ·Client Value Creation ·Teamwork ·Humanity ·Integrity ·Professionalism ·Client Value Creation ·Teamwork ·
About Us
0+

Years building
healthier societies

0+African markets
0Service lines
2017Founded
Mission

To sustainably build healthy and prosperous societies in Africa by delivering bespoke, contextually relevant business solutions and services to life science companies and organizations.

Who We Are

Ryculture Health and Social Innovation is a forward-looking social enterprise committed to improving access to safe, effective and quality health products and services across Africa through sustainable market-based models.

Founded in 2017, the company focused its foundational years in understanding the African healthcare markets through pragmatic community-based socially relevant health programs. Grounded on experiences and insights gained, in 2025 we committed our efforts to operate as a partner of choice helping life science companies and organizations deliver innovative and quality healthcare solutions in the continent.

We are your gateway to African life science markets — with services spanning programmatic, regulatory and commercial models.

Vision

A healthy, socially responsible and prosperous society.

Healthcare professionals
Medical team collaboration
Community health program
Strategic advisory session
Pharmaceutical and regulatory work
Our Services

What we do

01

Talent Management

Building the human capital that drives Africa's health sector — from frontline workers to executive leadership.

Talent Management

  • Health workforce assessments & planning
  • Bespoke training program design
  • Leadership development & coaching
  • Recruitment, placement & retention
Explore Service →
02

Business Ecosystem Support

Connecting health businesses with the partnerships, capital, and market intelligence they need to scale.

Business Ecosystem Support

  • Business development & market entry
  • Investor readiness & fundraising support
  • Strategic partnerships & ecosystem mapping
  • Growth advisory & operational consulting
Explore Service →
03

Regulatory Affairs

End-to-end regulatory strategy, submissions, and lifecycle management across African markets.

Regulatory Affairs

  • Regulatory intelligence monitoring & analysis
  • Dossier filing across 29+ African countries
  • Product lifecycle & variation management
  • Import processing & market authorization
Explore Service →
04

Pharmacovigilance

Robust safety monitoring and post-market surveillance programs to protect patients and ensure compliance.

Pharmacovigilance

  • Vigilance system design & implementation
  • Safety signal monitoring & management
  • Post-market surveillance programs
  • QPPV services & regulatory reporting
Explore Service →
05

Media Strategy

Strategic health communications that build trust, shift narratives, and move audiences to action.

Media Strategy

  • Health brand positioning & messaging
  • Digital & social media strategy
  • Stakeholder & public affairs engagement
  • Content production & campaign management
Explore Service →

Projects

Community Pharmacy Partnership (CPP)

Targeted Demand Generation for Injectable Contraceptives

Market Assessment for Biotherapeutics in 6 African Countries

Stories & Insights

From the field.

All Stories →
Policy
Policy5 October 2026

Behind the Curtain: What a Workshop on Economic Modelling Taught Me About the Cost of Care

A five-day health economics workshop in Nairobi brought together stakeholders to examine the true cost of Kenya’s response to non-communicable diseases. Focusing on stroke and chronic kidney disease, the experience highlighted a critical imbalance: too much spending is directed toward costly late-stage treatment, while prevention, early screening, community education, and timely intervention remain underfunded. For the author, the workshop revealed that every health policy and clinical decision carries economic consequences for patients, families, and the health system. It also reinforced the urgent need for pharmacists to contribute more actively to NCD planning, cost-effectiveness discussions, and pharmacoeconomics in Kenya.

Read Story →
Regulatory Affairs
Regulatory Affairs24 September 2026

Critical Considerations in Pharmacovigilance of Medical Devices and In-Vitro Diagnostics

The article highlights the need to expand patient safety efforts beyond medicines and vaccines to include strong vigilance for medical devices and in-vitro diagnostics (IVDs). These technologies are central to healthcare, but their risks often emerge after use in real-world settings. It stresses that device and IVD vigilance must monitor both safety and performance, since malfunctions, false results, software issues, poor maintenance, or user errors can lead to delayed diagnosis, misdiagnosis, or patient harm. The article calls for stronger post-market surveillance systems, better reporting pathways, user feedback, literature screening, trained personnel, and collaboration among regulators, manufacturers, healthcare workers, laboratories, and patients. For Africa, it frames materiovigilance as a key patient safety and market-shaping priority as the continent expands access to health technologies and strengthens regulatory systems.

Read Story →
Get Involved

Ready to build something that lasts?

Whether you are a partner organization, a young professional, a researcher, or a community — there is a place for you in what we are building.

01

Partner with us

Collaborate on programs, research or funding.

02

Join our programs

YouTH Voices, Social Innovation Hub and more.

03

Work with us

Careers and volunteer opportunities.